Neuland Laboratories Limited officially announced the passing of Dr. Christopher M Cimarusti, a Non-Executive Non-Independent Director on its Board. Dr. Cimarusti, who held DIN 02872948, passed away on February 28, 2026. The company expressed deep sorrow, noting his significant vision and contributions, especially to the R&D function, since joining the Board in 2009.
Intimation of Director’s Passing
Neuland Laboratories Limited formally notified the stock exchanges regarding the sad demise of Dr. Christopher M Cimarusti. Dr. Cimarusti served as a Non-Executive Non-Independent Director on the company’s Board.
Key Details of Cessation
The necessary details pertaining to the cessation of his directorship, as mandated by disclosure requirements, are summarized below:
- DIN: 02872948
- Reason for Change: Death
- Date of Cessation: February 28, 2026
Legacy and Contribution
Dr. Cimarusti had been associated with the Board since 2009. The company stated that its growth benefited immensely from his vision, guidance, and valuable contributions, particularly highlighting his impact on the R&D function throughout his tenure. The Directors and all employees conveyed their deepest condolences to his family during this period of grief.
The company confirmed that all other required disclosures regarding his profile and relationships between directors were Not Applicable.
Source: BSE
